Basic Information
| LncRNA/CircRNA Name | UNC5B-AS1 |
| Synonyms | NA |
| Region | GRCh38_10:71217224-71218228 |
| Ensemble | ENSG00000237512 |
| Refseq | NR_038453 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | papillary thyroid cancer |
| ICD-0-3 | NA |
| Methods | qPCR, RNA-seq |
| Sample | PTC tissues,cell lines (TPC1 and BCPAP) |
| Expression Pattern | up-regulated |
| Function Description | These results suggested that the lncRNA UNC5B-AS1 was significantly upregulated in both the TCGA cohort and our tissue cohort. |
| Pubmed ID | 30805847 |
| Year | 2019 |
| Title | The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines. |
External Links
| Links for UNC5B-AS1 | GenBank HGNC NONCODE |
| Links for papillary thyroid cancer | OMIM COSMIC |